Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

IST will do nothing to this stock. It's a non-event, and not what investors have been anticipating. Need something much more positive, anything that involves a cash transfer to Advaxis except for the dilutive raise.
The absence of news always means a bad news here. We will tank. Once we reach 10M market cap, the company will seek for a Ch11 or Ch7 protection. Just what KB did at ROSG. This translates to a share price in 1.40 area. There's no way the company can raise any substantial amount of money via secondary. They must be delusional to think so.